Table 2 Final set of additional quality indicators resulting from consensus process
Nr. | Category | Subject | Nominator | Denominator | Comments |
|---|---|---|---|---|---|
1 | General aspects/ efficiency | Contiuity of care (UPC index) | Sum of insured persons with consultation at the regular GP | Sum of insured persons with consultation (total: regular GP, GP, specialist) | Continuity of care threshold: Low (< 0.75), High (≥0.75); Only insured persons with ≥3 consultations were considered due to potential bias with small number of consultations. Additional option: Sum of insured persons with consultation at the regular GP/ Sum of insured persons with consultation at the GP |
2 | General aspects/ efficiency | Management continuity between hospital and GP (among persons ≥65 years) | Sum of insured persons aged 65 year or older who encountered a GP within 4 weeks after hospital discharge | Sum of insured persons aged 65 year or older who were discharged from hospital | Supplementary material: Sum of insured persons aged 65 year or older who encountered a healthcare provider within 4 weeks after hospital discharge/ Sum of insured persons aged 65 year or older who were discharged from hospital |
3 | General aspects/ efficiency | Prescription ratio of biosimilars | Sum of insured persons with biosimilar prescriptions | Sum of insured persons with biosimilar or biological prescriptions | |
4 | Laboratory testing | Vitamin D testing | Sum of insured persons who received Vitamin D testing | Sum of insured persons | Additional option: Sum of insured persons who received multiple/ repeated Vitamin D test / Sum of insured persons ≥1 Vitamin D test |
5 | Laboratory testing | Potassium check during diuretic therapy | Sum of insured persons aged 75 with loop diuretic/thiazide prescriptions who received a potassium check within a year | Sum of insured persons aged 75 with loop diuretic prescriptions | |
6 | Osteoarthritis | Arthroscopic knee intervention without prior physiotherapy | Sum of insured persons without physiotherapy 6 months prior to arthroscopic knee intervention | Sum of insured persons with knee arthroscopy | Additional option: Sum of insured persons who had GP consultation of knee imaging 6 months prior to knee arthroscopy/ Sum of insured persons with knee arthroscopy Cave: Exclude accidents from the analytic study sample. |
7 | Drug safety | Potentially inappropriate use of proton pump inhibitor | Sum of insured persons with Potentially inappropriate use of proton pump inhibitor prescription | Sum of insured persons | Operationalization is based on Muheim et al. (2021) |
8 | Drug safety | Potentially inappropriate use of opioids | Sum of insured persons with potentially inappropriate opioid prescription | Sum of insured persons | Operationalization is based on Wertli et al. (2017) |
9 | Drug safety | Iron infusion without prior diagnostics and oral treatment | Sum of insured persons who received an iron infusion without receiving 1 month prior a ferritin test and an oral iron therapy | Sum of insured persons who received an iron infusion | Relevance in women much higher than in men. Additional option: Sum of insured persons who received an iron infusion without prior ferritin test and/or oral iron therapy |